Relative to its peers, OGEN does not have very much institutional sponsorship. The 13.74% of shares outstanding held by institutional investors is among the least of any stock in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CITADEL ADVISORS LLC Bought 3.9 Thousand shares of Oragenics Inc
RBC PRIVATE COUNSEL (USA), INC. Bought 300.00 shares of Oragenics Inc
MORGAN STANLEY SMITH BARNEY LLC Bought 8.00 shares of Oragenics Inc